Business
Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.
Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc. Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative companies at the forefront of biotechnology and life sciences. MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its l
About this update from Moderna, Inc.
[{"type":"text","content":"Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.","length":69,"tagName":"p"},{"type":"image","alt":"Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative companies at the forefront of biotechnology and life sciences.","displaySize":"","headline":null,"caption":"Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative companies at the forefront of biotechnology and life sciences.","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1000,"height":1000,"url":"https://media.zenfs.com/en/globenewswire.com/dc74227d86810998402b72d2c80b0dfc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wn25cW2GMiMTuUQpFG1ijw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/dc74227d86810998402b72d2c80b0dfc","width":960,"height":960},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/PnNSAUEyC7cGvOnQ.bJ5wA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/dc74227d86810998402b72d2c80b0dfc","width":640,"height":640},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/cRil45DX4Hcw1TdBBjgN0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwMDA7aD0yMDAwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/dc74227d86810998402b72d2c80b0dfc","width":1000,"height":1000}}},{"type":"text","content":"MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative companies at the forefront of biotechnology and life sciences.","length":324,"tagName":"p"},{"type":"text","content":"MRNX is designed for traders seeking magnified, short-term bullish exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company known for its messenger RNA (mRNA)–based medicines and vaccine development platform. By seeking to deliver 200% of the daily percentage change in the share price of Moderna, Inc., the Fund allows...